TETRALOGY OF FALLOT
Clinical trials for TETRALOGY OF FALLOT explained in plain language.
Never miss a new study
Get alerted when new TETRALOGY OF FALLOT trials appear
Sign up with your email to follow new studies for TETRALOGY OF FALLOT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New No-Scalpel heart valve offers hope for patients with leaky or narrow valves
Disease control OngoingThis study tests a new device called the PULSTA valve, which is placed inside the heart through a tube in a blood vessel, avoiding open-heart surgery. It is for people with a damaged pulmonary valve that either leaks or is too narrow. The study includes 58 patients and checks if …
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New heart valve system under watch for congenital patients
Disease control OngoingThis study tracks how well a new heart valve system works in 150 people born with heart defects that cause a leaky pulmonary valve. The valve is placed using a thin tube through a blood vessel, avoiding open-heart surgery. Researchers are checking if the valve is placed correctly…
Matched conditions: TETRALOGY OF FALLOT
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
New heart valve fix could spare patients from Open-Heart surgery
Disease control OngoingThis study tests a new device combination (Alterra Prestent and SAPIEN 3 valve) to repair a leaky pulmonary heart valve in people born with heart defects. About 86 participants with moderate or severe leakage will get the device through a tube in a blood vessel, avoiding open-hea…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New heart valve device offers hope for patients with congenital heart defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and rebuild the right ventricular outflow tract in people with congenital heart defects. The study includes 15 participants aged 5 and older who need this surgery. The main goal is to see if the…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated May 18, 2026 12:11 UTC